SIC
Starr International Company Portfolio holdings
AUM
$19.9M
This Quarter Return
-19.73%
1 Year Return
-39.69%
3 Year Return
-26.08%
5 Year Return
-43.79%
10 Year Return
-39.24%
AUM
$59.9M
AUM Growth
+$59.9M
(+20%)
Cap. Flow
+$9.64M
Cap. Flow
% of AUM
16.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
3
Top Buys
| 1 |
Celularity
CELU
|
$44.2M |
Top Sells
| 1 |
Moderna
MRNA
|
$25.8M |
| 2 |
AstraZeneca
AZN
|
$5.59M |
| 3 |
Johnson & Johnson
JNJ
|
$3.23M |
Sector Composition
| 1 | Healthcare | 73.86% |
| 2 | Financials | 26.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Celularity
CELU
$94.4M
| $44.2M | 73.86% | +8,640,695 | New | +$44.2M |
|
2
Bain Capital Specialty
BCSF
$1.03B
| $12.1M | 20.18% | 794,543 | – | – |
|
3
American International
AIG
$45.1B
| $3.57M | 5.96% | 62,788 | – | – |
|
|
4
AstraZeneca
AZN
$248B
| – | – | -93,000 | Closed | -$5.59M |
|
|
5
Johnson & Johnson
JNJ
$427B
| – | – | -20,000 | Closed | -$3.23M |
|
|
6
Moderna
MRNA
$9.37B
| – | – | -67,000 | Closed | -$25.8M |
|